Seboquiro, Erline Jhyl M.

HRN: 22-23-54  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/21/2022
METRONIDAZOLE 500MG (TAB)
11/21/2022
11/28/2022
PO
500mg
Q8
S/P NSD; Thickly MSAF
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: